1-2 of 2
Kazuki Yamaguchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quantitative Estimation of the In Vivo Equivalent Factor VIII Activity of NXT007, an Emicizumab-Based, Next-Generation, Activated Factor VIII-Mimetic Bispecific Antibody, from Nonclinical Data

Koichiro Yoneyama, Tetsuhiro Soeda, Kazuki Yamaguchi, Takuya Miwa, Takaaki Ishida, Tomohisa Saito
Journal: Blood
Blood (2022) 140 (Supplement 1): 11295–11296.
https://doi.org/10.1182/blood-2022-155918
Published: 2022
Journal Articles

Pharmacology and Pharmacokinetics of NXT007; Emicizumab-Based Engineered Fixa/Fx Bispecific Antibody with Improved Properties

Kazuki Yamaguchi, Tetsuhiro Soeda, PhD, Motohiko Sato, Norihito Shibahara, PhD, Hikaru Koga, Mina Ichiki, Eri Joyashiki, Yuri Teranishi, Kei Nishimura, Hirotake Shiraiwa, Hidetomo Kitamura, PhD DVM, Tomoyuki Igawa, PhD, Hiroko Konishi, Takehisa Kitazawa, DVM
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-138958
Published: 2020